Cleared Special

K143169 - MyGlucoHealth Wireless System

K143169 is the FDA 510(k) clearance for MyGlucoHealth Wireless System by Entra Health Systems. It is a Class 2 Chemistry device (product code NBW) cleared through the Special 510(k) pathway after a 430-day FDA review.

K143169 · Entra Health Systems · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2016
Decision
430d
Days
Class 2
Risk

K143169 is an FDA 510(k) clearance for the MyGlucoHealth Wireless System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Entra Health Systems (San Diego, US). The FDA issued a Cleared decision on January 8, 2016 after a review of 430 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Chemistry submissions.

View all Entra Health Systems devices

Submission Details

510(k) Number K143169 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 04, 2014
Decision Date January 08, 2016
Days to Decision 430 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
342d slower than avg
Panel avg: 88d · This submission: 430d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 236
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K143169.
iHealth Align Gluco-Monitoring system
K153286 · Andon Health Co, Ltd. · Aug 2016
StatStrip Xpress Blood Glucose Monitoring System
K160156 · Nova Biomedical Corporation · Jun 2016
FreeStyle Precision Neo H Blood Glucose Monitoring System
K153330 · Abbott Diabetes Care, Inc. · Feb 2016
Freestyle Freedom Blood Glucose Monitoring Sytem
K152442 · Abbott Laboratories · Dec 2015
iHealth Align Gluco-Monitoring System, iHealth BG5 wireless Smart Gluco-Monitoring System, iHealth BG5L wireless Smart Gluco-Monitoring System
K150833 · Andon Health Co, Ltd. · Dec 2015
Autosure Voice II Blood Glucose Monitoring System, Autosure Voice II Pro Blood Glucose Monitoring System, Autosure Blood Glucose Test Strips, Autosure Pro Blood Glucose Test Strips
K150396 · Apex BioTechnology Corp. · Oct 2015